Mirum Pharmaceuticals, Inc.
MIRM
$100.64
$1.871.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 43.91% | 39.11% | 36.75% | 32.03% | 9.41% |
| Total Receivables | 36.06% | 38.87% | 57.54% | 56.33% | 76.79% |
| Inventory | 12.33% | 13.83% | 11.09% | 11.24% | 12.25% |
| Prepaid Expenses | 41.01% | 65.03% | 53.94% | 98.01% | 121.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 40.34% | 38.61% | 39.94% | 37.23% | 23.26% |
|
|
|||||
| Total Current Assets | 40.34% | 38.61% | 39.94% | 37.23% | 23.26% |
| Net Property, Plant & Equipment | 41.02% | 71.69% | 8.04% | -5.51% | 2.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.00% | 4.23% | 4.44% | -9.34% | -9.13% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 227.48% | 203.68% | 132.48% | 79.12% | 73.42% |
| Total Assets | 43.97% | 29.07% | 25.65% | 17.55% | 9.85% |
|
|
|||||
| Total Accounts Payable | 32.68% | 410.34% | -34.23% | 27.47% | 79.40% |
| Total Accrued Expenses | 48.99% | 91.15% | 48.76% | 37.10% | 33.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.57% | 43.13% | 25.16% | 35.13% | 94.12% |
| Total Finance Division Other Current Liabilities | 69.09% | 76.42% | 125.38% | 43.54% | 11.91% |
| Total Other Current Liabilities | 69.09% | 76.42% | 125.38% | 43.54% | 11.91% |
| Total Current Liabilities | 53.86% | 113.85% | 62.62% | 38.54% | 28.93% |
|
|
|||||
| Total Current Liabilities | 53.86% | 113.85% | 62.62% | 38.54% | 28.93% |
| Long-Term Debt | 142.80% | 0.56% | 0.56% | 0.55% | 0.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 32.74% | 59.57% | -5.72% | -13.20% | -4.37% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 696.01% | 289.73% | 99.72% | 302.34% | 127.95% |
| Total Liabilities | 124.24% | 41.89% | 18.65% | 13.12% | 9.01% |
|
|
|||||
| Common Stock & APIC | 64.78% | 90.53% | 12.83% | 12.02% | 10.04% |
| Retained Earnings | -129.41% | -121.25% | -3.63% | -6.68% | -9.66% |
| Treasury Stock & Other | -291.48% | 89.15% | 194.10% | -95.98% | 173.79% |
| Total Common Equity | -104.08% | 3.96% | 39.47% | 25.87% | 11.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -104.08% | 3.96% | 39.47% | 25.87% | 11.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -104.08% | 3.96% | 39.47% | 25.87% | 11.43% |
|
|
|||||